Mihaljevic, A., Büchler, P., Harder, J., Hofheinz, R., Gregor, M., Kanzler, S., . . . Geissler, M. (2009). A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer. BioMed Central.
Stile di citazione ChicagoMihaljevic, Andre, et al. A Prospective, Non-randomized Phase II Trial of Trastuzumab and Capecitabine in Patients With HER2 Expressing Metastasized Pancreatic Cancer. BioMed Central, 2009.
Citazione MLAMihaljevic, Andre, et al. A Prospective, Non-randomized Phase II Trial of Trastuzumab and Capecitabine in Patients With HER2 Expressing Metastasized Pancreatic Cancer. BioMed Central, 2009.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.